Detection, analysis and clinical validation of chromosomal aberrations by multiplex ligation-dependent probe amplification in chronic leukemia

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Abdool, Adam ^a   Donahue, Amber C ^a   Wohlgemuth, Jay G ^a   Yeh, Chen Hsiung ^a  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOMATION; CHROMOSOME 18Q; CHROMOSOME 19P; CHROMOSOME 19Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CHROMOSOME IDENTIFICATION; CHROMOSOME NUMBER; CHRONIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DIAGNOSTIC ACCURACY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; LEUKEMIA CELL; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; CHRONIC LYMPHATIC LEUKEMIA; GENE DOSAGE; GENETICS; POLYMERASE CHAIN REACTION;

HARNESS;

CHROMOSOME ABERRATIONS; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; POLYMERASE CHAIN REACTION;

EID: 78149436145     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015407     Document Type: Article

References (22)

1. Potti A, Dressman HK, Bild A, Riedel RF, Chan G, et al. (2006) Genomic signatures to guide the use of chemotherapeutics. Nat Med 12: 1294-1300.
2. Van Bockstaele F, Verhasselt B, Philippe ́ J (2009) Prognostic markers in chronic lymphocytic leukemia: a comprehensive review. Blood Rev 23: 25-47.
3. Croce CM (2008) Molecular origins of cancer: Oncogenes and Cancer. N Engl J Med 358: 502-511.
4. Greshock J, Feng B, Nogueira C, Ivanova E, Perna I, et al. (2007) A comparison of DNA copy number profiling platforms. Cancer Res 67: 10173-10180.
5. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, et al. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. NEngl J Med 343: 1910-1916.
6. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, et al. (2008) International Workshop on Chronic Lymphocytic Leukemia. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the InternationalWorkshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111: 5446-5456.
7. Grever MR, Lucas DM, Dewald GW, Neuberg DS, Reed JC, et al. (2007) Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997. J Clin Oncol 25: 799-804.
8. Guipaud O, Deriano L, Salin H, Vallat L, Sabatier L, et al. (2003) B-cell chronic lymphocytic leukaemia: a polymorphic family unified by genomic features. Lancet Oncol 4: 505-514.
9. Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, et al. (1990) Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 323: 720-724.
10. Dohner H, Stilgenbauer S, Dohner K, Bentz M, Lichter P (1999) Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J Mol Med 77: 266-281.
11. Barrett MT, Scheffer A, Ben-Dor A, Sampas N, Lipson D, et al. (2004) Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. Proc Natl Acad Sci 101: 17765-17770.
12. Pinkel D, Albertson DG (2005) Array comparative genomic hybridization and its applications in cancer. Nat Genet 37: S11-17.
13. Coll-Mulet L, Santidrian AF, Cosialls AM, Iglesias-Serret D, de Frias M, et al.(2008) Multiplex ligation-dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukaemia. Br J Haematol 142: 793-801.
14. Al Zaabi EA, Fernandez LA, Sadek IA, Riddell DC, Greer WL (2010) Multiplex ligation-dependent probe amplification versus multiprobe fluorescence in situhybridization to detect genomic aberrations in chronic lymphocytic leukemia: a tertiary center experience. J Mol Diagn 12: 197-203.
15. Schwaenen C, Nessling M, Wessendorf S, Salvi T, Wrobel G, et al. (2004) Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci 101: 1039-1044.
16. Liehr T, Starke H, Weise A, Lehrer H, Claussen U (2004) Multicolor FISH probe sets and their applications. Histol Histopathol 19: 229-237.
17. Stevens-Kroef M, Simons A, Gorissen H, Feuth T, Weghuis DO, et al. (2009) Identification of chromosomal abnormalities relevant to prognosis in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification. Cancer Genet Cytogenet 195: 97-104.
18. Sellmann L, Gesk S, Walter C, Ritgen M, Harder L, et al. (2007) Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia. Br J Haematol 138: 217-220.
19. Schutte M (1999) DPC4/SMAD4 gene alterations in human cancer, and their functional implications. Ann Oncol Suppl 4: 56-59.
20. Schiemann WP, Rotzer D, Pfeifer WM, Levi E, Rai KR, et al. (2004) Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor. Cancer Detect Prev 28: 57-64.
21. Kim WY, Sharpless NE (2006) The regulation of INK4/ARF in cancer and aging. Cell 127: 265-275.
22. Tsang HT, Connell JW, Brown SE, Thompson A, Reid E, et al. (2006) A systematic analysis of human CHMP protein interactions: additional MIT domain-containing proteins bind to multiple components of the human ESCRT III complex. Genomics 88: 333-346.